Issue link: https://viewer.e-digitaledition.com/i/196089
at Las vegas (uNLv) will conduct these tests. one to two hours post-operatively and nine recent meta-analysis and randomized trials," uNLv will also be providing genotype analy- out of the 10 patients were ambulatory says Dr. barnett. "unlike therapies using ion- sis for all participants as a way to integrate within hours. response and survival was also izing radiation, Neuroblate therapy results in genetic medicine into drug discoveries. the nearly 10 and one-half months, better than tumor death at the time of the procedure. a research team will be looking at whether expected for patients with such advanced larger national study will be developed, as a patients with various kinds of apolipoprotein disease." result of this initial success." e (apoe) gene have different responses to bexarotene. "previous attempts using less invasive ap- Dr. Sloan and Dr. barnett are paid consul- proaches such as brachytherapy and stereo- tants for monteris medical and members of tactic radiosurgery have proven ineffective in the company's medical advisory board. ■ NEW MRi-GUiDED LASER FoR BRAiN TUMoR SHoWS PRoMiSE the first-in-human study of the Neuroblate thermal therapy System finds that it appears to provide a new, safe and minimally invasive procedure for treating recurrent glioblastoma (gbm), a malignant type of brain tumor. the study, which appeared april 5 in the Journal of Neurosurgery online, was written by lead author andrew Sloan, mD, Director of brain tumor and Neuro-oncology Center at university hospitals (uh) Case medical Center, uh Seidman Cancer Center and Case Comprehensive Cancer Center. he served as co-principal investigator with principal investigator gene barnett, mD, Director of the brain tumor and Neuro-oncology Center at Cleveland Clinic and Case Comprehensive Cancer Center. Neuroblate is a device that "cooks" brain Source: Hospice Perception Study 2010 tumors in a controlled fashion to destroy them. it uses a minimally invasive, mriguided laser system to coagulate, or heat and kill, brain tumors. the procedure is conducted in an mri machine, enabling surgeons to plan, steer and see in real time the device, the heat map of the area treated by the laser and the tumor tissue that has been coagulated. the study was a phase i clinical trial investigating the safety and performance of We want to change that statistic. This is just one of the surprising statistics revealed by a nation-wide survey of physicians. And that's why Crossroads Hospice wants to help medical professionals understand more about hospice and how much patients and families can benefit. To do that, we've sponsored and published a variety of papers like the one written by Physicians Practice magazine: What Every Doctor Should Know About Hospice. Neuroblate (formerly known as autoLitt), a specially designed laser probe system. the paper describes the treatment of the 3 easy ways to get your free whitepaper. first 10 patients with this technology. these 1. Scan this QR code patients, who had a median age of 55, had tumors which were diagnosed to be inoper- 2. Email info@CrossroadsHospice.com (subject line: Every Doctor) able or "high risk" for open surgical resection 3. Visit CrossroadsHospice.com/md2 because of their location. "overall the Neuroblate procedure was well-tolerated," says Dr. Sloan. "all 10 patients were alert and responsive within Fast, easy referrals: 888-909-6673 • CrossroadsHospice.com/md2 NovEmBEr /dECEmBEr ■ mdNEWS.Com ■ MD News Cleveland/Akron/Canton | 35